Astrana Health, Inc. (ASTH) Stock Analysis

Astrana Health, Inc. (ASTH) Stock Analysis — AI Research | MarketCI

ASTH

Market Closed

Astrana Health, Inc.

NASDAQHealthcare Medical - Care Facilities

1.90K employees

CEO: Brandon K. Sim

Founded: 2009

$39.85

+$0.00(+NaN%)

Market Cap

1.98B

Beta

0.94

52W Range

N/A

Dividend Yield

0.00%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

ASTH Price Chart

Historical price performance

Loading MCI price data...

MarketCI Investment Signals

AI-synthesized investment signal for ASTH built from valuation, fundamentals, sentiment, and risk models

Investment Signal

Hold

Pass %

57.14%

Score

4/7

Fair Value Estimate

Cash flow analysis • Multiple methods

$58.55

AI Price Target

Machine learning • Price prediction

$27.06

Market Sentiment

News & social media analysis

0.00

Value Investor Price

Classic value analysis

$10.44

Financial Health

Bankruptcy risk assessment

2.59

Quality Score

Financial strength rating

5.00

AI Investment Grade

Deep analysis of filings & news

68.00

Key Investment Highlights

Important factors affecting ASTH investment thesis

Due Diligence Analysis

Investment criteria assessment and scoring

Overall Assessment

48.84% Poor

Conditions Met

21.00/43.00

Due Diligence Score

48.84%

Due Diligence Conditions

Investment analysis conditions and results


	Pass
	Fail
	Fail
	Pass
	Fail
	Pass

Showing 1 to 6 of 46 conditions